source
- Biotech VC Forbion raises record €2.3 bn ($2.6 bn) to back 30 high-potential life-science companiesForbion announced a record fundraising of €2.3 bn ($2.6 bn) across two new funds, bringing its assets under management to about €7.5 bn ($8.4 bn). The capital will be allocated through the Forbion…
- ARPA-H launches Surpass program to speed and broaden clinical trialsThe U.S. Department of Health and Human Services announced a new initiative called Surpass, aimed at removing obstacles that slow clinical development and changing how trials are designed and run.…